Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Biton, Victor; Gil-Nagel, Antonio; Isojarvi, Jouko; Doty, Pamela; Hebert, David; Fountain, Nathan B.
; 52(Pt A): 119-27, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26414341
The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
Lacosamide add-on therapy for partial epilepsy.
Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures.
Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy.
Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures.
Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial.